Transforming
Breast Health
Through
Imaging
Intelligence
The first platform combining
QT ultrasound, AI, and biomarkers
for safer, earlier, more accurate care.
Introducing the QTI Breast
Acoustic CT™ Scanner
The first platform combining Quantitative Transmission (QT) ultrasound, AI, and biomarkers for safer, earlier, more accurate care.
Latest News
A New Standard of Reproducibility for Quantitative Biomarkers in Breast Imaging
QT Imaging, a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported the characterization of repeatability and reproducibility metrics for quantitative biomarkers generated by its QT Imaging Breast Acoustic CT™ Scanner platform.
QT Imaging Receives Saudi Arabia FDA Regulatory Clearance
QT Imaging today announced that its Breast Acoustic CT™ scanner has received official classification and clearance from the Kingdom of Saudi Arabia (KSA) for use as a medical device in that country.
QT Imaging Set to Join the Russell Microcap® Index
The addition of QT Imaging to this Index will be finalized at the conclusion of the 2026 Russell indexes reconstitution and, if affirmed, will be effective when the U.S. market opens on June 29, 2026.
Transforming Breast Health.
For Every Woman.
At QT Imaging, we are redefining what’s possible in breast imaging—delivering safe, high-resolution, and cost-effective solutions where traditional technologies fall short. Our goal is to make advanced diagnostic imaging accessible to all women, including those with dense breast tissue or limited access to care. With a platform rooted in innovation, clinical validation, and artificial intelligence (AI) integration, we are committed to building a future where early, accurate breast cancer detection is available without compromise.
Chief Executive Officer,
QT Imaging Holdings, Inc.
Key Clinical Highlights
Screening in Low Resource or Mobile Settings
Most breast imaging technologies require expensive, specialized facilities for their operation. For example, digital mammography / DBT, breast CT, MRI use ionizing radiation, so the exam rooms need lead shielding inside the walls to protect staff and other patients from radiation exposure…
Elimination of Operator Dependency
Hand-held ultrasound (HHUS) is often used as a supplemental breast cancer screening tool in conjunction with mammography. Studies show that HHUS improves cancer detection for women with dense breasts when used in addition to screening mammography…
Safe Imaging for Patients with MRI Contraindications
Breast magnetic resonance imaging (MRI) is commonly used to screen women with a high risk for breast cancer. Research has found that breast MRIs can locate small breast lesions missed by mammography…
Accurate Diagnosis in Dense Breasts
High breast density is common. In the US, 40%-50% of women ages 40-74 have dense breasts, and it is even more common for young women. Having high breast density means that a woman’s breasts have a higher portion…
Reducing Overdiagnosis & Unnecessary Follow-ups
Mammography has a low positive predictive value. Studies show mammography leads to unnecessary follow-up procedures — such as handheld ultrasound or MRI imaging and biopsies — leading to unnecessary patient…
Safe Breast Imaging Without X-Ray Exposure
2D X-ray digital mammography (XRM) and 3D digital breast tomosynthesis (DBT) are the principal breast imaging modalities currently used for mass screening of asymptomatic women with an average risk of breast cancer…